Status:
UNKNOWN
Use of Hair to Diagnose Breast Cancer
Lead Sponsor:
Fermiscan Ltd
Conditions:
Breast Cancer
Eligibility:
FEMALE
20+ years
Phase:
PHASE2
Brief Summary
This study aims to perform x-ray diffraction analysis of blinded hair samples from women with a documented health status, to validate the previous findings of James et al who described that x-ray diff...
Eligibility Criteria
Inclusion
- Adult women (aged \>20) who are undergoing mammography, and
- Who are willing and able to provide informed consent; and
- Who have usable scalp hair
Exclusion
- Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN: cervical intra-epithelial neoplasia) within 5 years.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00390377
Start Date
October 1 2006
Last Update
October 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St George Private Hospital
Sydney, New South Wales, Australia, 2217